You are here
- Home
- Drug Products
- All Drug Products
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Generic Name
- Dapagliflozin
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- I
- Start Date
- Jan 1, 2010
- Study Name
- D1691C00002
- Study Id
- D1691C00002
- ClinicalTrials.gov ID
- NCT01055691
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Aug 4, 2010
- D1691C00002.pdf (127 KB)
